Abstract
Infection with dengue virus (DV) can result in dengue hemorrhagic fever and dengue shock syndrome, where patients suffer from bleeding and plasma leakage involving endothelial cells. Angiopoietins (Ang) 1 and 2 are important angiogenic factors that affect endothelial barrier integrity. In this study, DV was observed to induce endothelial leakage at multiplicity of infection of 10 in primary human umbilical vein endothelial cells (HUVEC) with interendothelial gap formation. Immunostaining of vascular endothelial cadherin (VE-cadherin) and zona occludin 1 (ZO-1) showed the absence of these endothelial junctional proteins at the cell–cell contact zones between adjacent cells. In addition, Ang1 that is required for protecting against endothelial hyperpermeability was found to be down-regulated during DV infection. Treatment with increasing concentrations of recombinant Ang1 was shown to prevent DV-induced endothelial hyperpermeability in a dose-dependent manner by preventing the down-regulation of VE-cadherin and ZO-1 at cell membrane. In contrast, the expression of Ang2, the natural antagonist of Ang1, was observed to be up-regulated during DV infection. Recombinant Ang2 added to HUVEC at non-toxic concentrations showed decreased in transendothelial electrical resistance reading and the down-regulation of VE-cadherin and ZO-1. These findings suggest that DV reduces the expression of Ang1 and enhances the expression of Ang2 in endothelial cells and that this imbalance of Ang 1 and Ang 2 may play a contributing role to the increased permeability of human primary endothelial cells during DV infection.
Similar content being viewed by others
References
Halstead SB (2007) Dengue. Lancet 370(9599):1644–1652. doi:10.1016/S0140-6736(07)61687-0
Huang YH, Lei HY, Liu HS, Lin YS, Liu CC, Yeh TM (2000) Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg 63(1–2):71–75
Vandenbroucke E, Mehta D, Minshall R, Malik AB (2008) Regulation of endothelial junctional permeability. Ann N Y Acad Sci 1123:134–145. doi:10.1196/annals.1420.016
Lei HY, Yeh TM, Liu HS, Lin YS, Chen SH, Liu CC (2001) Immunopathogenesis of dengue virus infection. J Biomed Sci 8(5):377–388
Butthep P, Chunhakan S, Tangnararatchakit K, Yoksan S, Pattanapanyasat K, Chuansumrit A (2006) Elevated soluble thrombomodulin in the febrile stage related to patients at risk for dengue shock syndrome. Pediatr Infect Dis J 25(10):894–897. doi:10.1097/01.inf.0000237918.85330.b9
Cardier JE, Rivas B, Romano E, Rothman AL, Perez-Perez C, Ochoa M, Caceres AM, Cardier M, Guevara N, Giovannetti R (2006) Evidence of vascular damage in dengue disease: demonstration of high levels of soluble cell adhesion molecules and circulating endothelial cells. Endothelium 13(5):335–340. doi:10.1080/10623320600972135
Jacobs M, Levin M (2002) An improved endothelial barrier model to investigate dengue haemorrhagic fever. J Virol Methods 104(2):173–185
Liu P, Woda M, Ennis FA, Libraty DH (2009) Dengue virus infection differentially regulates endothelial barrier function over time through type I interferon effects. J Infect Dis 200(2):191–201. doi:10.1086/599795
Dalrymple NA, Mackow ER (2012) Endothelial cells elicit immune-enhancing responses to dengue virus infection. J Virol 86(12):6408–6415. doi:10.1128/JVI.00213-12
Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Yancopoulos GD (1996) Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87(7):1161–1169
Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277(5322):55–60
Kwak HJ, So JN, Lee SJ, Kim I, Koh GY (1999) Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett 448(2–3):249–253
Gamble JR, Drew J, Trezise L, Underwood A, Parsons M, Kasminkas L, Rudge J, Yancopoulos G, Vadas MA (2000) Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res 87(7):603–607
Saharinen P, Eklund L, Miettinen J, Wirkkala R, Anisimov A, Winderlich M, Nottebaum A, Vestweber D, Deutsch U, Koh GY, Olsen BR, Alitalo K (2008) Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell–cell and cell-matrix contacts. Nat Cell Biol 10(5):527–537. doi:10.1038/ncb1715
Kim I, Moon SO, Park SK, Chae SW, Koh GY (2001) Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ Res 89(6):477–479
Oh H, Takagi H, Suzuma K, Otani A, Matsumura M, Honda Y (1999) Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 274(22):15732–15739
Roviezzo F, Tsigkos S, Kotanidou A, Bucci M, Brancaleone V, Cirino G, Papapetropoulos A (2005) Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Ther 314(2):738–744. doi:10.1124/jpet.105.086553
Mofarrahi M, Nouh T, Qureshi S, Guillot L, Mayaki D, Hussain SN (2008) Regulation of angiopoietin expression by bacterial lipopolysaccharide. Am J Physiol Lung Cell Mol Physiol 294(5):L955–L963. doi:10.1152/ajplung.00449.2007
Hwang JY, Park JW, Hong SY, Park HS (2009) Reduced expression of angiopoietin-1 in Hantaan virus-infected human umbilical vein endothelial cell increases their permeability. Acta Virol 53(1):7–13
Burgess A, Vigneron S, Brioudes E, Labbe J-C, Lorca T, Castro A (2010) Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance. Proc Natl Acad Sci USA 107(28):12564–12569. doi:10.1073/pnas.0914191107
Dewi BE, Takasaki T, Kurane I (2004) In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection. J Virol Methods 121(2):171–180. doi:10.1016/j.jviromet.2004.06.013
Ferrero E, Zocchi MR, Magni E, Panzeri MC, Curnis F, Rugarli C, Ferrero ME, Corti A (2001) Roles of tumor necrosis factor p55 and p75 receptors in TNF-alpha-induced vascular permeability. Am J Physiol Cell Physiol 281(4):C1173–C1179
Bhattacharya R, Sinha S, Yang SP, Patra C, Dutta S, Wang E, Mukhopadhyay D (2008) The neurotransmitter dopamine modulates vascular permeability in the endothelium. J Mol Signal 3:14. doi:10.1186/1750-2187-3-14
Gotsch U, Borges E, Bosse R, Boggemeyer E, Simon M, Mossmann H, Vestweber D (1997) VE-cadherin antibody accelerates neutrophil recruitment in vivo. J Cell Sci 110(Pt 5):583–588
Daly C, Wong V, Burova E, Wei Y, Zabski S, Griffiths J, Lai KM, Lin HC, Ioffe E, Yancopoulos GD, Rudge JS (2004) Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). Genes Dev 18(9):1060–1071. doi:10.1101/gad.1189704
Peters S, Cree IA, Alexander R, Turowski P, Ockrim Z, Patel J, Boyd SR, Joussen AM, Ziemssen F, Hykin PG, Moss SE (2007) Angiopoietin modulation of vascular endothelial growth factor: effects on retinal endothelial cell permeability. Cytokine 40(2):144–150. doi:10.1016/j.cyto.2007.09.001
Giamarellos-Bourboulis EJ, Kanellakopoulou K, Pelekanou A, Tsaganos T, Kotzampassi K (2008) Kinetics of angiopoietin-2 in serum of multi-trauma patients: correlation with patient severity. Cytokine 44(2):310–313. doi:10.1016/j.cyto.2008.09.003
Talavera D, Castillo AM, Dominguez MC, Gutierrez AE, Meza I (2004) IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol 85(Pt 7):1801–1813. doi:10.1099/vir.0.19652-0
Lee YR, Liu MT, Lei HY, Liu CC, Wu JM, Tung YC, Lin YS, Yeh TM, Chen SH, Liu HS (2006) MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J Gen Virol 87(Pt 12):3623–3630. doi:10.1099/vir.0.82093-0
Chuang YC, Lei HY, Liu HS, Lin YS, Fu TF, Yeh TM (2011) Macrophage migration inhibitory factor induced by dengue virus infection increases vascular permeability. Cytokine 54(2):222–231. doi:10.1016/j.cyto.2011.01.013
Ong SP, Lee LM, Leong YF, Ng ML, Chu JJ (2012) Dengue virus infection mediates HMGB1 release from monocytes involving PCAF acetylase complex and induces vascular leakage in endothelial cells. PLoS ONE 7(7):e41932. doi:10.1371/journal.pone.0041932
Andrews BS, Theofilopoulos AN, Peters CJ, Loskutoff DJ, Brandt WE, Dixon FJ (1978) Replication of dengue and junin viruses in cultured rabbit and human endothelial cells. Infect Immun 20(3):776–781
Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis FA, Nisalak A (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181(1):2–9. doi:10.1086/315215
Arevalo MT, Simpson-Haidaris PJ, Kou Z, Schlesinger JJ, Jin X (2009) Primary human endothelial cells support direct but not antibody-dependent enhancement of dengue viral infection. J Med Virol 81(3):519–528. doi:10.1002/jmv.21408
Wu HM, Yuan Y, Zawieja DC, Tinsley J, Granger HJ (1999) Role of phospholipase C, protein kinase C, and calcium in VEGF-induced venular hyperpermeability. Am J Physiol 276(2 Pt 2):H535–H542
Minshall RD, Vandenbroucke EE, Holinstat M, Place AT, Tiruppathi C, Vogel SM, van Nieuw Amerongen GP, Mehta D, Malik AB (2010) Role of protein kinase Czeta in thrombin-induced RhoA activation and inter-endothelial gap formation of human dermal microvessel endothelial cell monolayers. Microvasc Res 80(2):240–249. doi:10.1016/j.mvr.2010.04.007
Goldberg PL, MacNaughton DE, Clements RT, Minnear FL, Vincent PA (2002) p38 MAPK activation by TGF-beta1 increases MLC phosphorylation and endothelial monolayer permeability. Am J Physiol Lung Cell Mol Physiol 282(1):L146–L154
He P, Zeng M, Curry FE (1998) cGMP modulates basal and activated microvessel permeability independently of [Ca2 +]i. Am J Physiol 274(6 Pt 2):H1865–H1874
Garcia JG, Davis HW, Patterson CE (1995) Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J Cell Physiol 163(3):510–522. doi:10.1002/jcp.1041630311
Alexander JS, Jackson SA, Chaney E, Kevil CG, Haselton FR (1998) The role of cadherin endocytosis in endothelial barrier regulation: involvement of protein kinase C and actin-cadherin interactions. Inflammation 22(4):419–433
Gonzalez-Mariscal L, Tapia R, Chamorro D (2008) Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 1778(3):729–756. doi:10.1016/j.bbamem.2007.08.018
Kanlaya R, Pattanakitsakul SN, Sinchaikul S, Chen ST, Thongboonkerd V (2009) Alterations in actin cytoskeletal assembly and junctional protein complexes in human endothelial cells induced by dengue virus infection and mimicry of leukocyte transendothelial migration. J Proteome Res 8(5):2551–2562. doi:10.1021/pr900060g
Ochoa CD, Stevens T (2012) Studies on the cell biology of interendothelial cell gaps. Am J Physiol Lung Cell Mol Physiol 302(3):L275–L286. doi:10.1152/ajplung.00215.2011
Kayakabe K, Kuroiwa T, Sakurai N, Ikeuchi H, Kadiombo AT, Sakairi T, Matsumoto T, Maeshima A, Hiromura K, Nojima Y (2012) Interleukin-6 promotes destabilized angiogenesis by modulating angiopoietin expression in rheumatoid arthritis. Rheumatology (Oxford) 51(9):1571–1579. doi:10.1093/rheumatology/kes093
Scott BB, Zaratin PF, Gilmartin AG, Hansbury MJ, Colombo A, Belpasso C, Winkler JD, Jackson JR (2005) TNF-alpha modulates angiopoietin-1 expression in rheumatoid synovial fibroblasts via the NF-kappa B signalling pathway. Biochem Biophys Res Commun 328(2):409–414. doi:10.1016/j.bbrc.2004.12.180
Azizan A, Sweat J, Espino C, Gemmer J, Stark L, Kazanis D (2006) Differential proinflammatory and angiogenesis-specific cytokine production in human pulmonary endothelial cells, HPMEC-ST1.6R infected with dengue-2 and dengue-3 virus. J Virol Methods 138(1–2):211–217. doi:10.1016/j.jviromet.2006.08.010
Chaturvedi UC, Nagar R (2009) Nitric oxide in dengue and dengue haemorrhagic fever: necessity or nuisance? FEMS Immunol Med Microbiol 56(1):9–24. doi:10.1111/j.1574-695X.2009.00544.x
Scherbik SV, Brinton MA (2010) Virus-induced Ca2 + influx extends survival of west Nile virus-infected cells. J Virol 84(17):8721–8731. doi:10.1128/JVI.00144-10
Komarova Y, Malik AB (2010) Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu Rev Physiol 72:463–493. doi:10.1146/annurev-physiol-021909-135833
Gavard J, Patel V, Gutkind JS (2008) Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell 14(1):25–36. doi:10.1016/j.devcel.2007.10.019
David S, Ghosh CC, Mukherjee A, Parikh SM (2011) Angiopoietin-1 requires IQ domain GTPase-activating protein 1 to activate Rac1 and promote endothelial barrier defense. Arterioscler Thromb Vasc Biol 31(11):2643–2652. doi:10.1161/ATVBAHA.111.233189
Azizan A, Fitzpatrick K, Signorovitz A, Tanner R, Hernandez H, Stark L, Sweat M (2009) Profile of time-dependent VEGF upregulation in human pulmonary endothelial cells, HPMEC-ST1.6R infected with DENV-1, -2, -3, and -4 viruses. Virol J 6:49. doi:10.1186/1743-422X-6-49
Bosch I, Xhaja K, Estevez L, Raines G, Melichar H, Warke RV, Fournier MV, Ennis FA, Rothman AL (2002) Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J Virol 76(11):5588–5597
Warke RV, Xhaja K, Martin KJ, Fournier MF, Shaw SK, Brizuela N, de Bosch N, Lapointe D, Ennis FA, Rothman AL, Bosch I (2003) Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J Virol 77(21):11822–11832
Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, Karumanchi SA, Sukhatme VP (2006) Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 3(3):e46. doi:10.1371/journal.pmed.0030046
Tanaka S, Wands JR, Arii S (2006) Induction of angiopoietin-2 gene expression by COX-2: a novel role for COX-2 inhibitors during hepatocarcinogenesis. J Hepatol 44(1):233–235. doi:10.1016/j.jhep.2005.09.012
Yamakawa M, Liu LX, Date T, Belanger AJ, Vincent KA, Akita GY, Kuriyama T, Cheng SH, Gregory RJ, Jiang C (2003) Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res 93(7):664–673. doi:10.1161/01.RES.0000093984.48643.D7
Huerta-Zepeda A, Cabello-Gutierrez C, Cime-Castillo J, Monroy-Martinez V, Manjarrez-Zavala ME, Gutierrez-Rodriguez M, Izaguirre R, Ruiz-Ordaz BH (2008) Crosstalk between coagulation and inflammation during Dengue virus infection. Thromb Haemost 99(5):936–943. doi:10.1160/TH07-08-0438
Wu WL, Ho LJ, Chang DM, Chen CH, Lai JH (2009) Triggering of DC migration by dengue virus stimulation of COX-2-dependent signaling cascades in vitro highlights the significance of these cascades beyond inflammation. Eur J Immunol 39(12):3413–3422. doi:10.1002/eji.200939306
Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh GY (2000) Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway. Circ Res 86(1):24–29
Korff T, Ernst E, Nobiling R, Feldner A, Reiss Y, Plate KH, Fiedler U, Augustin HG, Hecker M (2012) Angiopoietin-1 mediates inhibition of hypertension-induced release of angiopoietin-2 from endothelial cells. Cardiovasc Res 94(3):510–518. doi:10.1093/cvr/cvs124
Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N, Sobke A, Herrmann M, Preissner KT, Vajkoczy P, Augustin HG (2006) Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 12(2):235–239. doi:10.1038/nm1351
Yuan HT, Khankin EV, Karumanchi SA, Parikh SM (2009) Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium. Mol Cell Biol 29(8):2011–2022. doi:10.1128/MCB.01472-08
Niedzwieckii S, Stepien T, Kopec K, Kuzdak K, Komorowski J, Krupinskii R, Stepien H (2006) Angiopoietin 1 (Ang-1), angiopoietin 2 (Ang-2) and Tie-2 (a receptor tyrosine kinase) concentrations in peripheral blood of patients with thyroid cancers. Cytokine 36(5–6):291–295. doi:10.1016/j.cyto.2007.02.008
Felcht M, Luck R, Schering A, Seidel P, Srivastava K, Hu J, Bartol A, Kienast Y, Vettel C, Loos EK, Kutschera S, Bartels S, Appak S, Besemfelder E, Terhardt D, Chavakis E, Wieland T, Klein C, Thomas M, Uemura A, Goerdt S, Augustin HG (2012) Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling. J Clin Invest 122(6):1991–2005. doi:10.1172/JCI58832
Srikiatkhachorn A, Green S (2010) Markers of dengue disease severity. Curr Top Microbiol Immunol 338:67–82. doi:10.1007/978-3-642-02215-9_6
Kanazawa H, Nomura S, Asai K (2007) Roles of angiopoietin-1 and angiopoietin-2 on airway microvascular permeability in asthmatic patients. Chest 131(4):1035–1041. doi:10.1378/chest.06-2758
Kumpers P, David S, Haubitz M, Hellpap J, Horn R, Brocker V, Schiffer M, Haller H, Witte T (2009) The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus. Ann Rheum Dis 68(10):1638–1643. doi:10.1136/ard.2008.094664
Giuliano J, Lahni P, Harmon K, Wong H, Doughty L, Carcillo J, Zingarelli B, Sukhatme V, Parikh S, Wheeler D (2007) Admission angiopoietin levels in children with septic shock. Shock (Augusta, Ga) 28(2677f927-7476-9a3d-3251-1fe7ac661419):650–1304
Lukasz A, Hellpap J, Horn R, Kielstein J, David S, Haller H, Kumpers P (2008) Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: development and clinical application of two new immunoassays. Critical care (London, England) 12 (f83da33e-e1bd-1985-d6e1-1fe12c2b80b3). doi:10.1186/cc6966
Michels M, van der Ven AJ, Djamiatun K, Fijnheer R, de Groot PG, Griffioen AW, Sebastian S, Faradz SM, de Mast Q (2012) Imbalance of Angiopoietin-1 and Angiopoietin-2 in Severe Dengue and Relationship with Thrombocytopenia, Endothelial Activation, and Vascular Stability. Am J Trop Med Hyg. doi:10.4269/ajtmh.2012.12-0020
Jain V, Lucchi NW, Wilson NO, Blackstock AJ, Nagpal AC, Joel PK, Singh MP, Udhayakumar V, Stiles JK, Singh N (2011) Plasma levels of angiopoietin-1 and -2 predict cerebral malaria outcome in Central India. Malar J 10:383. doi:10.1186/1475-2875-10-383
Brown H, Rogerson S, Taylor T, Tembo M, Mwenechanya J, Molyneux M, Turner G (2001) Blood-brain barrier function in cerebral malaria in Malawian children. Am J Trop Med Hyg 64(3–4):207–213
Acknowledgments
This study is supported by Start-up grants (R182-000-000-165-133 and R182-000-165-733) and Defence Innovative Research Programme grants (R182-000-210-232, R182-000-210-234, and PA9011104293).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ong, S.P., Ng, M.L. & Chu, J.J.H. Differential regulation of angiopoietin 1 and angiopoietin 2 during dengue virus infection of human umbilical vein endothelial cells: implications for endothelial hyperpermeability. Med Microbiol Immunol 202, 437–452 (2013). https://doi.org/10.1007/s00430-013-0310-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00430-013-0310-5